[ad_1]
The National Pharmaceutical Authority has ordered the withdrawal from the market of several batches of drugs containing the active substance called valsartan, used to treat high blood pressure, as an impurity has been discovered, says Infarmed. under the European system of suspension of drugs was detected only in drugs whose active substance valsartan was manufactured by a company in China. "The Member States of the European Union, in collaboration with the European Medicines Agency (EMA), have set up as a precaution the collection of lots throughout the distribution network of potentially affected medicines" he explains. recommends that patients who use the medications concerned do not discontinue treatment and contact the doctor or pharmacist to prescribe or issue a substitution drug to the gold
The National Drug Authority specifies in addition that there are drugs of the same substance active substance or with valsartan associated with another substance that will not be withdrawn from the market because it does not appear on the list established by the authorities and will therefore remain on the market. Other drugs available on the market with the same therapeutic indications are still on the market and are an alternative.
Source link
